Dr. Mark Holterman’s Contribution to Research and Regenerative Medicine

Mark Holterman, MD, Ph.D. is a practicing pediatric surgeon at OSF Healthcare where he practices general pediatric surgery in the children’s hospital. He is a member of the American Diabetes Association (ADA), which recently announced its partnership with Children’s Hospital Los Angeles to tackle the growing problem of type 2 diabetes in children and teenagers. The two organizations will employ evidence-based physical activities to encourage the youngsters to make healthier food choices and engage in physical exercises to prevent the onset of type 2 diabetes. Dr. Holterman received ADA’s Innovative Research Award due to his commitment to research in diabetes cures and prevention measures.

holterman pic

Contribution to Regenerative Medicine

 

Dr. Mark Holterman’s is contributing to the nonprofit organization the Alliance for the Advancement of Cellular Therapies (AACT) by serving as a member of the board. The organization brings together physicians, device manufacturers, researchers and scientists for the advancement of regenerative medicine and cell therapy. Members of the organization enjoy many benefits such as discounted rates to workshops and conferences, access to the European Medicine Agency and the FDA in the USA to express their opinions, among many others. This is with the aim of developing best practices in the field of regenerative medicine. Through AACT, members also get networking opportunities and the latest news in regenerative medicine through the organization’s newsletter.

 

Background and Work

 

Dr. Mark Holterman graduated from Yale University and the University of Virginia and has specialized in pediatric surgery and regenerative medicine for many years. Dr. Holterman is currently the CEO and Chief Medical Officer at Mariam Global Health, which focuses on the complexities of regenerative medicine. Additionally, Dr. Mark Holterman is a professor of surgery and pediatrics at the University of Illinois College of Medicine-Peoria.

 

Conclusion

 

Dr. Holterman has previously worked as an attending surgeon at Rush University Medical Center and served as Surgeon in Chief at Advocate’s Children’s Hospital. He has also worked as a professor at the University of Illinois where he was responsible for developing basic and translational research programs (About.me). Dr. Mark Holterman’s interest in research saw him work as a research associate in immunology research at the Clinical Research Institute of Montreal. After pursuing a fellowship in pediatric surgery at Seattle Children’s, he served as an instructor in surgery at the University of Washington.

 

More about Dr. Mark Holterman at https://www.behance.net/MarkJHolterman